Regenerative medicine is an exciting field that will open doors to the development of more sustainable and more effective therapeutic solutions for cardiovascular disease.“ In the words of Paula Alves, CEO of iBET, “ It is very rewarding to set up a network of excellence in the field of cardiac regenerative medicine. IBET and Genibet Biopharmaceuticals will play a key role in the development of technologies and protocols for the production and characterisation of different types of cells and cell-based products for application in regenerative medicine.
Where can i purchase the ios program for mac Patch#
In addition, the project will develop a 3D device to enable patch implementation through less invasive methods, and a 3D system to streamline its production and transport. The consortium will develop a patch of collagen fibres functionalised with stem cells to optimize its therapeutic benefit and regenerative ability. IBET researchers Margarida Serra and Marta Costa were present at CARDIOPATCH project kick-off meeting held virtually on December 15 th-16 th, 2020.ĬARDIOPATCHproject, funded by the EU Interreg Sudoe Programme, aims to develop an innovative strategy to regenerate damaged tissue after myocardial infarction.
0 kommentar(er)
